Glucocorticoid-regulated adipose tissue secretion of PAI-1, but not IL-6, TNFα or leptin in Vivo

Hormone and Metabolic Research

Volumn 34, Issue 11-12, 2002, Pages 698-702

  Udden J ^a   Eriksson, P ^a   Hoffstedt, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipose Tissue; Glucocorticoids; Obesity; PAI 1 and Protein Secretion

Indexed keywords

BETA ACTIN; GLUCOCORTICOID; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CYTOKINE RELEASE; ENDOCRINE FUNCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; METABOLIC DISORDER; MORBIDITY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN SECRETION; TISSUE METABOLISM; VENOUS BLOOD;

EID: 0036875659     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-38257     Document Type: Article

References (34)

1. Kirk LF, Hasch RB, Katner HP, Jones T. Cushing's disease: clinical manifestations and diagnostic evaluation. Amer Fam Physician 2000; 62: 1119-1127
2. Rosmond R, Bjorntorp P. The interactions between hypothalamic-pituitary- adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men. Int J Obes Relat Metab Disord 1998; 22: 1184-1196
3. Bjorntorp P, Rosmond R. Obesity and cortisol. Nutrition 2000; 16: 924-926
4. Ottosson M, Lonnroth P, Bjorntorp P, Eden S. Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 2000; 85: 799-825
5. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72-75
6. Alessi MC, Morange P, Juhan-Vague I. Fat cell function and fibrinolysis. Horm Metab Res 2000; 32: 504-508
7. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherosclerosis via insulin resistance and obesity. Ann Med 2000; 32: 78-84
8. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes 1998; 22: 312-317
9. Patrassi GM, Sartori MT, Livi U, Casonato A, Danesin C, Vettore S, Girolami A. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation. Transplantation 1997; 64: 1610-1614
10. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145-1158
11. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002; 5: 551-559
12. He G, Pedersen SB, Bruun JM, Richelsen B. Regulation of plasminogen activator inhibitor-1 in human adipose tissue; interaction between cytokines, cortisol and estrogen. Horm Metab Res 2000; 32: 515-520
13. Lasic S, Bobarevic N, Nikolin B. Simultaneous determination of prednisone, prednisolone, cortisol and dexamethasone in plasma by high-performance liquid chromatography. J Pharm Biomed Anal 1989; 7: 777-782
14. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988; 48: 1351-1361
15. Morange PE, Aubert J, Peiretti F, Lijnen HR, Vague P, Verdier M, Negrel R, Juhan-Vague I, Alessi MC. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 1999; 48: 890-895
16. Seki T, Miyasu T, Noguchi T, Hamasaki A, Sasaki R, Ozawa Y, Okukita K, Declerck PJ, Ariga T. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine pre-adipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes. Cell Physiol 2001; 189: 72-78
17. Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 1999; 84: 4097-4105
18. Sartori MT, Patrassi GM, Pontarollo S, Livi U, Angelini A, Theodoridis P, Fioretti M, Girolami A. relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. J Heart Lung Transplant 1999; 18: 693-700
19. Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JMP, Yudkin JS. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin Endocrinol 1999; 50: 221-228
20. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998; 41: 65-71
21. Alessi MC, Morange P, Juhan-Vague I. Fat cell function and fibrinolysis. Horm Metab Res 2000; 32: 504-508
22. Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coag Fibrinol 1992; 3: 789-793
23. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. A Rev Genet 1985; 19: 209-252
24. van Zonneveld AJ, Curriden SA, Loskutoff DJ. Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci USA 1988; 85: 5525-5529
25. Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1. production 2000; 85: 336-344
26. Song CZ, Tian X, Gelehrter TD. Glucocorticoid receptor inhibits transforming growth factor-beta signalling by directly targeting the transcriptional activation function of Smad 3. Proc Natl Acad Sci USA 1999; 96: 11776-11781
27. Vincennati V, Vottero A, Friedman C, Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 2002; 26: 905-911
28. Mazusaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K. Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 2542-2547
29. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab1998; 83: 847-850
30. Halleux CM, Servais I, Reul BA, Detry R, Brichard SM. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 1998; 83: 902-909
31. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997; 82: 1635-1637
32. Berg AL, Nilsson-Ehle P. Direct effects of corticotropin on plasma lipoprotein metabolism in man - studies in vivo and in vitro. Metabolism 1994; 43: 90-97
33. Berg AL, Nilsson-Ehle P, Arnadottir M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56: 1534-1543
34. McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988; 4: 17-30